Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lithium and valproate decrease the membrane phosphatidylinositol/phosphatidylcholine ratio.

Daobin Ding1, Miriam L Greenberg

  • 1Department of Biological Sciences, Wayne State University, Detroit, Michigan 48202, USA.

Molecular Microbiology
|January 10, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inositol biosynthesis is inversely regulated by glycolytic activity.

Biochimica et biophysica acta. Molecular and cell biology of lipids·2026
Same author

Valproate causes inositol depletion in yeast by decreasing levels of phosphatidic acid and increasing Opi1-mediated repression of INO1 expression.

Biochimica et biophysica acta. Molecular and cell biology of lipids·2026
Same author

The histone modification regulator, SIN3, plays a role in the cellular response to changes in glycolytic flux.

PloS one·2025
Same author

Decapping activators Edc3 and Scd6 act redundantly with Dhh1 in post-transcriptional repression of starvation-induced pathways.

eLife·2025
Same author

Valproate independently activates Snf1, inhibits TORC1, and induces repression of INO1 transcription by increasing nuclear localization of Opi1.

Scientific reports·2025
Same author

Emerging roles of pyruvate dehydrogenase phosphatase 1: a key player in metabolic health.

Frontiers in physiology·2025
Same journal

Riboflavin Salvage Supports Glycolysis in Borrelia burgdorferi Through Flavin-Dependent NAD<sup>+</sup> Regeneration.

Molecular microbiology·2026
Same journal

Distinct Spatial Organisation of Rho and RNA Polymerase in Salmonella Cells.

Molecular microbiology·2026
Same journal

A Single-Nucleotide Substitution Generates a de Novo Promoter That Activates a Latent Metabolic Bypass in Escherichia coli.

Molecular microbiology·2026
Same journal

A Phosphorylation-Dependent Partner-Switching-Like Module Regulates a Glycosyltransferase Required for Heterocyst Polysaccharide Layer Formation in Anabaena sp. Strain PCC 7120.

Molecular microbiology·2026
Same journal

Chain-Length Regulation by WzzE Is Necessary for, but Genetically Separable From, Cyclic Enterobacterial Common Antigen Synthesis.

Molecular microbiology·2026
Same journal

To Move or Not to Move: When and How Bacteria Suppress Flagellar Motility.

Molecular microbiology·2026
See all related articles

Lithium and valproate, anti-bipolar drugs, alter yeast cell membranes by reducing phosphatidylinositol and increasing phosphatidylcholine. This shift in phospholipid balance may impact cellular functions, offering insights into drug mechanisms.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Lithium and valproate are established anti-bipolar medications.
  • These drugs affect intracellular inositol levels and gene expression related to phospholipid synthesis in yeast.
  • Previous studies indicate these drugs influence phospholipid metabolism.

Purpose of the Study:

  • To investigate the effects of lithium and valproate on phosphatidylinositol and phosphatidylcholine synthesis and composition in yeast.
  • To determine the impact of these drugs on the expression of key genes involved in phospholipid metabolism.
  • To explore the implications of altered phospholipid ratios for cellular function and drug mechanisms.

Main Methods:

  • Measuring the relative rates of phosphatidylinositol and phosphatidylcholine synthesis.

Related Experiment Videos

  • Analyzing the steady-state composition of membrane phospholipids.
  • Quantifying the expression levels of phospholipid pathway genes (INO1, INO2, CHO1, OPI3).

    • Main Results:

    • Both lithium and valproate decreased phosphatidylinositol synthesis and composition.
    • Both drugs increased phosphatidylcholine synthesis.
    • Valproate, but not lithium, upregulated the expression of phosphatidylcholine pathway genes CHO1 and OPI3.
    • The phosphatidylinositol/phosphatidylcholine ratio was reduced by both drugs.

    Conclusions:

    • Lithium and valproate alter yeast membrane phospholipid composition by decreasing phosphatidylinositol and increasing phosphatidylcholine.
    • The observed reduction in the phosphatidylinositol/phosphatidylcholine ratio may be a key factor in the therapeutic action of these anti-bipolar drugs.
    • These findings suggest a link between phospholipid metabolism and the mechanism of action for mood-stabilizing medications.